Mannkind (MNKD) Income towards Parent Company (2010 - 2026)
Mannkind's (MNKD) quarterly Income towards Parent Company came in at -$16.6 million in Q1 2026, down 226.3% year-on-year from $13.2 million in Q1 2025, and down 4.21% on a QoQ basis from -$15.9 million in Q4 2025.
Mannkind (MNKD) Income towards Parent Company (2010 - 2026) Analysis & Trends
Mannkind (MNKD) has 17 years of Income towards Parent Company data on file, last reported at -$16.6 million in Q1 2026.
- On a quarterly basis, Income towards Parent Company fell 226.3% year-over-year to -$16.6 million in Q1 2026; TTM through Mar 2026 was -$23.9 million, a 179.53% decrease from a year earlier, with the FY2025 full-year figure at $5.9 million, down 78.75% from the prior year.
- Income towards Parent Company for Q1 2026 stood at -$16.6 million, down from -$15.9 million in the prior quarter.
- Over the last five years, Income towards Parent Company for MNKD reached as high as $13.2 million in Q1 2025 and fell as low as -$29.0 million in Q2 2022.
- Historically, Income towards Parent Company has averaged -$4.7 million across 5 years, with a median of -$2.0 million in 2024.
- Across the five-year window, Income towards Parent Company jumped 427.01% in 2024 and sank 315.08% in 2025, its largest moves.
- Year by year, Income towards Parent Company stood at -$17.9 million in 2022, then jumped by 107.84% to $1.4 million in 2023, then soared by 427.01% to $7.4 million in 2024, then sank by 315.08% to -$15.9 million in 2025, then fell by 4.21% to -$16.6 million in 2026.
- Per Business Quant data, the three most recent Income towards Parent Company figures were -$16.6 million in Q1 2026, -$15.9 million in Q4 2025, and $8.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Mannkind | 1.23 Bn | 1.10 Bn | 82.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -16.62 Mn |
| Dec 31, 2025 | -15.95 Mn |
| Sep 30, 2025 | 7.98 Mn |
| Jun 30, 2025 | 640,000.00 |
| Mar 31, 2025 | 13.16 Mn |
| Dec 31, 2024 | 7.42 Mn |
| Sep 30, 2024 | 11.55 Mn |
| Jun 30, 2024 | -2.01 Mn |
| Mar 31, 2024 | 10.63 Mn |
| Dec 31, 2023 | 1.41 Mn |
| Sep 30, 2023 | 3.58 Mn |
| Jun 30, 2023 | -5.27 Mn |
| Mar 31, 2023 | -9.80 Mn |
| Dec 31, 2022 | -17.95 Mn |
| Sep 30, 2022 | -14.43 Mn |
| Jun 30, 2022 | -29.02 Mn |
| Mar 31, 2022 | -26.00 Mn |
| Dec 31, 2021 | -28.06 Mn |
| Sep 30, 2021 | -4.43 Mn |
| Jun 30, 2021 | -35.52 Mn |